AGP Executive Report
Last update: 9 hours agoIndiana Business & Economy: Lilly’s experimental obesity drug EloraTZP beat its own Zepbound in a head-to-head mid-stage trial, with the top dose producing 23.3% average weight loss over 48 weeks versus 14.8% for Zepbound, plus larger A1C reductions in patients with diabetes. Health & Consumer Watch: Doctors renewed warnings about energy drinks for kids and teens, citing high caffeine and potential heart and nervous-system risks after a coalition urged the Big 12 to pause a Monster Energy sponsorship and asked the NCAA to review youth-focused marketing. Sports Betting & Local Interest: The Colts open NFL London play against the Commanders on Oct. 4, with market pricing showing Indianapolis as the favorite in prediction markets and multiple sportsbooks pushing new-customer promos around the matchup. Policy & Environment: The Trump administration’s proposed repeal of the federal Roadless Rule would affect millions of acres nationwide, including parts of Indiana’s Hoosier National Forest, raising concerns about losing protections for roadless areas. Tech & Taxes: Meta is reportedly treating AI data centers as “pilot models” for tax purposes to claim research credits, a strategy that could face IRS pushback.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
